StartEdge Logo

Contact Us

Contact Us

StartEdge Logo
StartEdge Logo

HealthTech & Diagnostics

Bartronics Partners with Huwel Life Sciences

Bartronics India Limited has entered into a strategic partnership with Huwel Life Sciences to support the scaling of affordable, high-quality diagnostic solutions. The collaboration focuses on expanding access, strengthening distribution, and enabling wider adoption of indigenously developed diagnostics across institutional and public health programs.

About Huwel Life Sciences: Innovation Meets Impact

A Women-Led Healthcare Pioneer

Founded and led by Dr. Rachana Tripathi, Huwel Life Sciences operates from a world-class ISO-certified, CE/FDA-compliant facility in Hyderabad. The company has developed over 100 validated diagnostic products across tuberculosis (TB), infectious diseases, antimicrobial resistance, viral threats, genetic disorders, and cancer.

Shape

Proven Track Record & Global Recognition

Pandemic Response Excellence

Delivered 52 million COVID-19 tests during the pandemic, recognized by NITI Aayog as a top startup company

International Credibility

Secured grants from Bill & Melinda Gates Foundation and received orders from World Health Organization (WHO)

Quality Standards

ISO 13485:2016, ISO 9001:2015, CE, US FDA, and MDR 2017 compliant with manufacturing capacity of 100+ million PCR tests annually

About Huwel Life Sciences: Innovation Meets Impact

A Women-Led Healthcare Pioneer

Founded and led by Dr. Rachana Tripathi, Huwel Life Sciences operates from a world-class ISO-certified, CE/FDA-compliant facility in Hyderabad. The company has developed over 100 validated diagnostic products across tuberculosis (TB), infectious diseases, antimicrobial resistance, viral threats, genetic disorders, and cancer.

Shape

Proven Track Record & Global Recognition

Pandemic Response Excellence

Delivered 52 million COVID-19 tests during the pandemic, recognized by NITI Aayog as a top startup company

International Credibility

Secured grants from Bill & Melinda Gates Foundation and received orders from World Health Organization (WHO)

Quality Standards

ISO 13485:2016, ISO 9001:2015, CE, US FDA, and MDR 2017 compliant with manufacturing capacity of 100+ million PCR tests annually

About Huwel Life Sciences: Innovation Meets Impact

A Women-Led Healthcare Pioneer

Founded and led by Dr. Rachana Tripathi, Huwel Life Sciences operates from a world-class ISO-certified, CE/FDA-compliant facility in Hyderabad. The company has developed over 100 validated diagnostic products across tuberculosis (TB), infectious diseases, antimicrobial resistance, viral threats, genetic disorders, and cancer.

Shape

Proven Track Record & Global Recognition

Pandemic Response Excellence

Delivered 52 million COVID-19 tests during the pandemic, recognized by NITI Aayog as a top startup company

International Credibility

Secured grants from Bill & Melinda Gates Foundation and received orders from World Health Organization (WHO)

Quality Standards

ISO 13485:2016, ISO 9001:2015, CE, US FDA, and MDR 2017 compliant with manufacturing capacity of 100+ million PCR tests annually

Flagship Innovation: Quantiplus® TB Solution

India's TB Game-Changer

The Quantiplus® TB Fast Detection Kit is the only open-system, affordable RT-PCR solution for TB confirmatory testing in India, approved by ICMR and launched by the Union Health Minister.

National Mission Alignment

Directly supports the government's National TB Elimination Programme (NTEP) and Prime Minister's vision of 'TB Mukt Bharat'. In 2023 alone, NTEP conducted 1.89 crore sputum smear tests and 68.3 lakh NAATs, demonstrating massive market need.

Key Features:

  • Extraction-free RT-PCR technology for rapid results

  • Open-system compatibility with most lab equipment

  • Compatible with UniAmp® portable NAT device for point-of-care testing

  • Validated through ICMR's multi-center clinical study

  • Affordable pricing for mass screening programs

Flagship Innovation: Quantiplus® TB Solution

India's TB Game-Changer

The Quantiplus® TB Fast Detection Kit is the only open-system, affordable RT-PCR solution for TB confirmatory testing in India, approved by ICMR and launched by the Union Health Minister.

National Mission Alignment

Directly supports the government's National TB Elimination Programme (NTEP) and Prime Minister's vision of 'TB Mukt Bharat'. In 2023 alone, NTEP conducted 1.89 crore sputum smear tests and 68.3 lakh NAATs, demonstrating massive market need.

Key Features:

  • Extraction-free RT-PCR technology for rapid results

  • Open-system compatibility with most lab equipment

  • Compatible with UniAmp® portable NAT device for point-of-care testing

  • Validated through ICMR's multi-center clinical study

  • Affordable pricing for mass screening programs

Flagship Innovation: Quantiplus® TB Solution

India's TB Game-Changer

The Quantiplus® TB Fast Detection Kit is the only open-system, affordable RT-PCR solution for TB confirmatory testing in India, approved by ICMR and launched by the Union Health Minister.

National Mission Alignment

Directly supports the government's National TB Elimination Programme (NTEP) and Prime Minister's vision of 'TB Mukt Bharat'. In 2023 alone, NTEP conducted 1.89 crore sputum smear tests and 68.3 lakh NAATs, demonstrating massive market need.

Key Features:

  • Extraction-free RT-PCR technology for rapid results

  • Open-system compatibility with most lab equipment

  • Compatible with UniAmp® portable NAT device for point-of-care testing

  • Validated through ICMR's multi-center clinical study

  • Affordable pricing for mass screening programs

About Huwel Life Sciences: Innovation Meets Impact

Huwel Life Sciences Brings

100+ validated diagnostic products

World-class R&D and manufacturing

Global certifications (ISO, CE, FDA)

Scientific innovation pipeline

Proven pandemic response record

Bartronics Brings

Scaling and market execution expertise

Technology integration capabilities

Government relationship management

Digital platform development

Commercial operations and contracts

Huwel Life Sciences Brings

100+ validated diagnostic products

World-class R&D and manufacturing

Global certifications (ISO, CE, FDA)

Scientific innovation pipeline

Proven pandemic response record

Bartronics Brings

Scaling and market execution expertise

Technology integration capabilities

Government relationship management

Digital platform development

Commercial operations and contracts

Huwel Life Sciences Brings

100+ validated diagnostic products

World-class R&D and manufacturing

Global certifications (ISO, CE, FDA)

Scientific innovation pipeline

Proven pandemic response record

Bartronics Brings

Scaling and market execution expertise

Technology integration capabilities

Government relationship management

Digital platform development

Commercial operations and contracts

Collaborative Growth Strategy

Collaborative Growth Strategy

Collaborative Growth Strategy

Joint R&D Initiatives - Beyond revenue, BIL and Huwel will drive R&D, launch new products, and expand internationally

Target Markets:

  • India - Government programs (NTEP, state health), private hospitals, diagnostic chains

  • Africa - Growing diagnostic infrastructure needs

  • Southeast Asia - Expanding healthcare systems

  • Global Markets - WHO programs, bilateral partnerships, emerging economies

Market Opportunity & Impact

The Healthcare Challenge

TB Burden - India accounts for significant global TB cases requiring massive-scale affordable diagnostics

Testing Scale - 1.89 crore sputum tests + 68.3 lakh NAATs in 2023 alone through NTEP

Quality Gap - Need for reliable, validated, international-standard products at accessible prices

Infrastructure - Growing network requiring point-of-care solutions for remote areas

Supporting National Missions

TB Mukt Bharat - Direct contribution to PM's TB-free India vision
Ayushman Bharat - Universal healthcare coverage with affordable diagnostics
Make in India - Manufacturing world-class products for global markets
Digital Health Mission - Technology-enabled diagnostic platforms

"Our vision is to create a monopoly-strength diagnostic portfolio that originates from India and serves the world. This partnership not only supports critical national health missions like TB elimination but also creates a robust, recurring revenue model for our business."

— N. Vidhya Sagar Reddy, Managing Director, Bartronics India Limited